Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases (eBook, PDF)
Redaktion: Qidwai, M. Tabish
52,95 €
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
52,95 €
Als Download kaufen
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
26 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
52,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
26 °P sammeln
Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases (eBook, PDF)
Redaktion: Qidwai, M. Tabish
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 5.59MB
Andere Kunden interessierten sich auch für
- Interaction of Coronavirus Disease 2019 with other Infectious and Systemic Diseases (eBook, ePUB)52,95 €
- Lynne M. BianchiThe Developing Brain and its Connections (eBook, PDF)81,95 €
- Senthilkumar RajagopalCalcium Signaling: From Physiology to Diseases (eBook, PDF)73,95 €
- Stem Cells and Neurodegenerative Diseases (eBook, PDF)52,95 €
- Alan LongstaffBIOS Instant Notes in Neuroscience (eBook, PDF)29,95 €
- Neurological Regeneration (eBook, PDF)73,95 €
- Composition and Function of Cell Membranes (eBook, PDF)73,95 €
-
-
-
The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 214
- Erscheinungstermin: 31. Oktober 2023
- Englisch
- ISBN-13: 9781000958447
- Artikelnr.: 68881159
- Verlag: Taylor & Francis
- Seitenzahl: 214
- Erscheinungstermin: 31. Oktober 2023
- Englisch
- ISBN-13: 9781000958447
- Artikelnr.: 68881159
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
M. Tabish Qidwai is M. Tech and PhD graduate of the Biotechnology Engineering at the Dr. A.P.J. Abdul Kalam Technical University Lucknow, India, and an Associate Professor in the SRM University, UP, India. He previously worked as officiating Director of IBST, SRM University, Assistant Professor at BB Ambedkar University, Lucknow. He is working in the area of infectious disease since more than one decade. He is working as section editor of Current Indian Science (Bentham Science). He has been awarded with several prestigious awards and appreciation letters.
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.
Tabish Qidwai
and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy
Sanjay Singh
Monisha Banerjee
and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava
Tabish Qidwai
and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima
Samina Wasi
Nikhat Jamal Siddiqi
and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari
Ankit Madeshiya
and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care
Prognosis
and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah
Shireen Masood
Amreen Shamsad
and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar
Osaid Masood
Shama Parveen
Sanjay Saini
and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms
Pharmacological Interventions
and Therapeutic Targets Ruchi Chawla
Mohini Mishra
Krishan Kumar
and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi
Sabiha Fathima
Sooad K. AlDaihan
Hanan A. Balto
and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary
Divya Chaudhary
and Vikas Mishra.